Researchers developed a deep-learning algorithm that analyzes senescence-associated secretory phenotype (SASP) proteins in blood to create a composite score measuring cellular aging burden. Using UK Biobank proteomics data from thousands of participants, their Guided Autoencoder with Transformer model successfully predicted mortality risk and incident chronic diseases including dementia, COPD, heart attack, and stroke. Notably, multimodal exercise interventions significantly improved SASP scores over 18 months in an independent clinical trial cohort. This represents a potentially transformative advance in aging biomarkers, as cellular senescence—the accumulation of damaged, zombie-like cells—is a fundamental driver of age-related disease. Unlike chronological age, this SASP score could measure biological aging and treatment responses in real-time. The approach addresses a critical gap in geroscience: quantifying senescence burden practically and affordably through standard blood draws rather than invasive tissue biopsies. However, as an unreviewed preprint, these promising results require peer review validation. The technology could eventually enable personalized longevity interventions by identifying individuals with high senescence loads before clinical symptoms emerge, though clinical implementation awaits further validation studies.